Waters (WAT) to Release Earnings on Tuesday

Waters (NYSE:WAT - Get Free Report) is anticipated to post its Q1 2025 quarterly earnings results before the market opens on Tuesday, May 6th. Analysts expect the company to announce earnings of $2.22 per share and revenue of $655.50 million for the quarter. Waters has set its Q1 2025 guidance at 2.170-2.250 EPS and its FY 2025 guidance at 12.700-13.000 EPS.

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping analysts' consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. On average, analysts expect Waters to post $13 EPS for the current fiscal year and $14 EPS for the next fiscal year.

Waters Stock Performance

Waters stock opened at $337.66 on Tuesday. The stock has a fifty day moving average price of $355.22 and a 200 day moving average price of $370.45. Waters has a 52 week low of $279.24 and a 52 week high of $423.56. The firm has a market capitalization of $20.09 billion, a P/E ratio of 31.53, a PEG ratio of 3.79 and a beta of 1.04. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Wells Fargo & Company upped their price target on shares of Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Barclays lowered their price target on Waters from $400.00 to $350.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Sanford C. Bernstein set a $400.00 price objective on Waters and gave the company an "outperform" rating in a research note on Wednesday, April 16th. StockNews.com lowered shares of Waters from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Finally, Robert W. Baird dropped their price objective on shares of Waters from $407.00 to $355.00 and set an "outperform" rating for the company in a research report on Tuesday, April 22nd. Ten equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $392.13.

Hedge Funds Weigh In On Waters

An institutional investor recently raised its position in Waters stock. Brighton Jones LLC raised its stake in shares of Waters Co. (NYSE:WAT - Free Report) by 112.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,269 shares of the medical instruments supplier's stock after acquiring an additional 673 shares during the quarter. Brighton Jones LLC's holdings in Waters were worth $471,000 at the end of the most recent quarter. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.